<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=windows-1251">
<title>V.Kretchikov, A.Dekhnich, I.Edelstein, A.Narezkina, M.Pimkin - Comparative Activity of Lincomycin and Clindamycin Against Staphylococcus aureus Isolated from Hospitalized Patients</title>
<meta name="description" content="Comparative Activity of Lincomycin and Clindamycin Against Staphylococcus Aureus Isolated from Hospitalized Patients">
<meta name="keywords" content="comparative activity, lincomycin, clindamycin, Staphylococcus aureus, hospitalized patients, Kretchikov, Dekhnich, Edelstein, Narezkina, Pimkin">
<script language="JavaScript1.2"> <!--//
function btn(ind,picture) {document.images[ind].src=picture;}
//--> </script>

<script language="JavaScript"> <!--// 
document.write('<link rel="StyleSheet" type="text/css" href="/en/inc/');
if (navigator.appName=="Netscape") {
	document.write("nn")
} else {
	document.write("ie")
}
document.write('.css">');
//-->
</script>
<noscript><link rel="StyleSheet" type="text/css" href="../../inc/ie.css"></noscript>

<style type="text/css">
P {margin-top: 10px; margin-left: 10px; text-align: justify;}
UL {margin-top: 6px; margin-left: 15px;}
OL {margin-top: 6px; margin-left: 25px;}
LI {margin-top: 8px; margin-left: 10px; text-align: justify;}
H4 {margin-left: 10px;}
H5 {font-size: 11pt;}
H5.l {text-align: left;}
</style>
</head>

<body class="main">

<table width="750" cellpadding="0" border="0" cellspacing="5">
<tr>
  <th width="150" valign="top">

  <table border="0" cellpadding="5" cellspacing="0" width="100%">
    <tr><td>
<p class="m10"><b>Antimicrobial Resistance</b></p>
<hr size="1" style="color: #D0C0AC;">
<p class="m8"><a href="../index.shtml#rus">Antimicrobial Resistance in Russia</a></p>
<p class="m8"><a href="../index.shtml#pub">Publications</a></p>
<p class="m8"><a href="../links.shtml">References</a></p>

    </td></tr>
  </table>
  

  </th><td valign="top">
<!--navigation-->
<map name="TopBtnEn">
<area shape="circle" coords="15,15,15" href="javascript:history.go(-1)" alt="Previous page" title="Previous page">
<area shape="circle" coords="46,15,15" href="javascript:history.go(+1)" alt="Next page" title="Next page">
<area shape="circle" coords="77,15,15" href="../../index-1.htm" alt="Main page" title="Main page">
<area shape="circle" coords="108,15,15" href="mailto:website@antibiotic.ru" alt="E-Mail" title="E-Mail">
</map>
<table border="0" cellpadding="0" cellspacing="0" width="100%"> <!--1-->
<tr>
  <td bgcolor="#F8F3E6" background="/rus/images/buttons/topline.gif" style="background-color: #F8F3E6; background-image: url(../../../rus/images/buttons/topline.gif);" width="98%" height="32"><img src="../../../rus/images/inv.gif" width="1" height="32" border="0" alt=""></td>
  <td width="1%"><font size="1"><img src="../../../rus/images/buttons/topbtn.gif" width="126" height="32" border="0" alt="Navigation" usemap="#TopBtnEn"></font></td>
</tr>
</table>
<!--/navigation-->

<h2><a name="top"></a>Proceedings of the Sixth International Conference on the Macrolides,
Azalides, Streptogramins, Ketolides and Oxazolidinones.</h2>
<h5><i>23-25 January, 2002, Bolgna, Italy</i><br>
<b>Poster # 03.13</b></h5>

<h1>Comparative Activity of Lincomycin and Clindamycin Against <i>Staphylococcus aureus</i> Isolated from Hospitalized Patients</h1>

<h5><i>VLADIMIR&nbsp;A.&nbsp;KRETCHIKOV, ANDREI&nbsp;V.&nbsp;DEKHNICH, INNA&nbsp;A.&nbsp;EDELSTEIN, ANNA&nbsp;D.&nbsp;NAREZKINA, MAXIM&nbsp;A.&nbsp;PIMKIN</i></h5>

<h5 class="l"><i>Institute of Antimicrobial Chemotherapy, Smolensk, Russia</i></h5>

<p style="text-align:right; font-size:8pt"><a href="../../pdfs/i0313.pdf">The PDF format poster (146 kb) <img src="../../images/pdf.gif" width="16" height="16" alt="" border="0"></a></p>

<hr size="1">
<ul>
   <li><a href="#1">Abstract</a></li>
   <li><a href="#2">Background</a></li>
   <li><a href="#3">Objective</a></li>
   <li><a href="#4">Methods</a></li>
   <li><a href="#5">Results</a></li>
   <li><a href="#6">Conclusion</a></li>
</ul>
<hr size="1">

<a name="1"></a><br>
<h2>ABSTRACT</h2>

<p><b>Background:</b> There are two lincosamyde antibiotics currently available in Russia -
lincomycin and clindamycin. <i>In vitro</i> activity of clindamycin against staphylococci
has been evaluated extensively, but there are a little data available on lincomycin.</p>

<p><b>Objective:</b> To compare the <i>in vitro</i> activity of clindamycin and lincomycin against
<i>S.aureus</i> isolated from hospitalized patients.</p>

<p><b>Methods:</b> A total of 555 clinical isolates of <i>S.aureus</i> obtained from hospitalised
patients from 16 centres in different regions of Russia has been studied.
Susceptibility to clindamycin and lincomycin was determined by agar dilution
method in accordance with the NCCLS recommendations. Interpretation of
susceptibility testing results for clindamycin was done according to the NCCLS
guidelines (no recommendations are available for lincomycin). The <i>S.aureus</i>
ATCC 29213 was used as a control strain.</p>

<p><b>Results:</b> MIC<sub>50</sub>, MIC<sub>90</sub> and MICs ranges for tested antimicrobials are shown in the table. Clindamycin was significantly more active than lincomycin against tested
strains. Its MIC in general was 4 dilutions lower than MIC of lincomycin. Moreover, 14 of clindamycin susceptible strains (MIC<u>&lt;</u>0.5 mg/l) have MIC for lincomycin <u>&gt;</u>128 mg/l.</p>

<table border="0" cellpadding="0" cellspacing="10" width="100%"><tr><td bgcolor="#CC9988">
<table width="100%" cellpadding="5" cellspacing="1" border="0">
<tr>
	<th width="25%" rowspan="2">&nbsp;</th>
	<th width="15%" rowspan="2">S, %</th>
	<th width="15%" rowspan="2">R + I, %</th>
	<th width="45%" colspan="3">MIC, mg/l</th>
</tr>
<tr>
	<th width="15%">MIC<sub>50</sub></th>
	<th width="15%">MIC<sub>90</sub></th>
	<th width="15%">Range</th>
</tr>
<tr>
	<td class="cl">Clindamycin</td>
	<td class="cc">79,6</td>
	<td class="cc">20,4</td>
	<td class="cc">0,125</td>
	<td class="cc">&gt;256</td>
	<td class="cc">0.06-&gt;256</td>
</tr>
<tr>
	<td class="cl">Lincomycin</td>
	<td class="cc">-</td>
	<td class="cc">-</td>
	<td class="cc">2</td>
	<td class="cc">&gt;256</td>
	<td class="cc">0.5-&gt;256</td>
</tr>
</table>
</td></tr></table>

<p><b>Conclusion:</b> Lincomycin has a significantly lower <i>in vitro</i> activity than clindamycin
against <i>S.aureus</i>, so, lincomycin should not be used for treatment of staphylococcal infections.</p>

<a name="2"></a><br>
<h2>BACKGROUND</h2>

<p>Among two lincosamydes available in Russia the <i>in vitro</i> activity of clindamycin
against staphylococci has been evaluated, but, unfortunately, there are a little data
available on lincomycin. We performed this study to obtain more data about
lincomycin activity against <i>S.aureus</i> isolated in Russian hospitals and to compare it
with clindamycin activity.</p>

<a name="3"></a><br>
<h2>OBJECTIVE</h2>

<p>To compare the <i>in vitro</i> activity of clindamycin and lincomycin against <i>S.aureus</i>
isolated from hospitalized patients.</p>

<a name="4"></a><br>
<h2>METHODS</h2>

<p><b>Strains:</b> A total of 555 clinical strains of <i>S.aureus</i> isolated in 2000-2001 from
patients hospitalized in 16 medical institutions in different parts of Russia (see
<a href="#f1">figure&nbsp;1</a>): 3 in Central region (Moscow, Ryazan, Smolensk), 2 in North-Western
region (St.-Petersburg), 3 in Southern region (Krasnodar, Stavropol), 2 in Volga
region (N.&nbsp;Novgorod, Kazan), 3 in Ural region (Ekaterinburg, Ufa), 3 in Siberia
(Krasnoyarsk, Novosibirsk, Tomsk) were included in the study.</p>

<p>All strains were shipped to a reference laboratory of Institute of Antimicrobial
Chemotherapy (Smolesnk, Russia) and re-identified there by standard biochemical
methods and stored at 70<sup>o</sup> C in glycerol broth.</p>

<p><b>Susceptibility testing:</b> Minimal inhibitory concentrations (MICs) to clindamycin and
lincomycin were determined by agar dilution method on Mueller-Hinton II agar
(BBL, USA). Interpretation of susceptibility testing results for clindamycin was done
according to the NCCLS guidelines (2001), but no recommendations are available
for lincomycin.</p>

<p><b>Quality control:</b> <i>S.aureus</i> ATCC 29213 was used as a control strain.</p>

<a name="f1">
<div align="center"><img src="images/0313r1.gif" width="559" height="274" alt="" border="0"></div>
<p><b>Figure 1.</b> Centers participated in the study</p><br><br>

<a name="5"></a><br>
<h2>RESULTS</h2>

<p>MIC<sub>50</sub>, MIC<sub>90</sub> and MICs ranges for tested antimicrobials are shown in the table. MICs distribution are presented on figures <a href="#f2">2</a> and <a href="#f3">3</a>. Clindamycin found to be significantly more active than lincomycin against tested strains. Its MIC in general was 4 dilutions lower than MIC of lincomycin. Moreover, 14 of clindamycin susceptible strains (MIC<u>&lt;</u>0.5 mg/l) have MIC for lincomycin <u>&gt;</u>128 mg/l.</p>

<br>
<p><b>Table.</b> <i>In vitro</i> activity clindamycin and lincomycin against <i>S.aureus</i></p>

<table border="0" cellpadding="0" cellspacing="10" width="100%"><tr><td bgcolor="#CC9988">
<table width="100%" cellpadding="5" cellspacing="1" border="0">
<tr>
	<th width="25%" rowspan="2">&nbsp;</th>
	<th width="15%" rowspan="2">S, %</th>
	<th width="15%" rowspan="2">R + I, %</th>
	<th width="45%" colspan="3">MIC, mg/l</th>
</tr>
<tr>
	<th width="15%">MIC<sub>50</sub></th>
	<th width="15%">MIC<sub>90</sub></th>
	<th width="15%">Range</th>
</tr>
<tr>
	<td class="cl">Clindamycin</td>
	<td class="cc">79,6</td>
	<td class="cc">20,4</td>
	<td class="cc">0,125</td>
	<td class="cc">&gt;256</td>
	<td class="cc">0.06-&gt;256</td>
</tr>
<tr>
	<td class="cl">Lincomycin</td>
	<td class="cc">-</td>
	<td class="cc">-</td>
	<td class="cc">2</td>
	<td class="cc">&gt;256</td>
	<td class="cc">0.5-&gt;256</td>
</tr>
</table>
</td></tr></table>

<a name="f2"><br>
<div align="center"><img src="images/0313r2.gif" width="435" height="326" alt="MIC distributions for clindamycin" border="0"></div>
<p><b>Figure 2.</b> MIC distributions for clindamycin</p>

<a name="f3"><br><br>
<div align="center"><img src="images/0313r3.gif" width="439" height="323" alt="" border="0"></div>
<p><b>Figure 3.</b> MIC distributions for lincomycin</p>

<a name="6"></a><br>
<h2>CONCLUSIONS</h2>

<ul>
<li>Lincomycin has a significantly lower <i>in vitro</i> activity than clindamycin against nosocomial <i>S.aureus</i>.</li>
<li>Lincomycin activity against <i>S.aureus</i> is doubtful, so the further clinical investigations are needed.</li>
</ul>

<hr size="1">

<br>
<!-- begin footer -->
<table border="0" cellpadding="5" cellspacing="0" width="100%">
<tr>
  <td style="text-align: left; vertical-align: bottom;" align="left" valign="bottom"><div class="t8">&copy; 2000-2006 IAC SSMA &middot; E-mail: <a href="mailto:website@antibiotic.ru" title="Send e-mail">website&#64;antibiotic&#46;ru</a></div></td>
  <td colspan="2" valign="top" align="right"><font size="1"><!-- SpyLOG v2 f:0211 --><script language="javascript">
u="u607.38.spylog.com";d=document;nv=navigator;na=nv.appName;p=1;
bv=Math.round(parseFloat(nv.appVersion)*100);
n=(na.substring(0,2)=="Mi")?0:1;rn=Math.random();z="p="+p+"&rn="+rn;y="";
y+="<a href='http://"+u+"/cnt?f=3&p="+p+"&rn="+rn+"' target=_blank>";
y+="<img src='http://"+u+"/cnt?"+z+
"&r="+escape(d.referrer)+"&pg="+escape(window.location.href)+"' border=0  width=88 height=31  alt='SpyLOG'>";
y+="</a>"; d.write(y);if(!n) { d.write("<"+"!--"); }//--></script><noscript>
<a href="../../../index-15.htm?f=3&p=1" target="_blank">
<img src="../../../digits.png?p=1" alt='SpyLOG' border='0' width="88" height="31">
</a></noscript><script language="javascript1.2"><!--
if(!n) { d.write("--"+">"); }//--></script><!-- SpyLOG  --></font></td>
</tr>
</table>
<!-- end of footer -->

  </td></tr>
</table>
</body>
</html>
